Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for medical industry professionals · Friday, September 18, 2020 · 526,522,383 Articles · 3+ Million Readers

Breast Cancer Therapeutics Market to Reach USD 38,573.5 Million at 10.2% CAGR by 2026, supported by Implementation of Favourable Reimbursement Policies, says Fortune Business Insights

Key Companies Covered in the Breast Cancer Therapeutics Market Research Report Are Biotechnology, Inc., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc., Eli Lilly and Company, Novartis International AG, AstraZeneca plc, F. Hoffmann-La Roche Ltd., Sanofi S.A., GlaxoSmithKline plc, Pfizer, Inc. and other key market players.

/EIN News/ -- Pune, Sept. 10, 2020 (GLOBE NEWSWIRE) -- The increasing number of breast cancer cases all over the world is anticipated to boost the global breast cancer therapeutics market at promising rates, finds Fortune Business Insights in a new study. The study is titled, “Breast Cancer Therapeutics Market: Global Market Analysis, Insights, and Forecasts”. According to the report, the global breast cancer therapeutics market, which stood at US$ 17,868.8 Mn in 2018, will reach [US$ 38,573.5 Mn] by the end of 2026. If these figures prove true, the global breast cancer therapeutics market will rise at a CAGR of 10.2% between 2018 and 2026.

According to the World Health Organization, in 2018, an approximate of 627,000 women, which is tantamount to 15% of all cancer deaths worldwide, succumbed to breast cancer. The rising incidence of breast cancer is one of the chief drivers of the global breast cancer therapeutics market.


Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/breast-cancer-therapeutics-market-100163


Highlights of the Report:

  • Analysis of the impact of Covid-19 that the market would face in the near future.
  • In-depth analysis of the growth drivers and obstacles.
  • Profile of all the companies operating in the market.
  • Elaborate data about the dominating region.
  • Competitive landscape consisting of mergers & acquisitions, investments, partnerships, new product launches, opening of new facilities, and new contracts.


An Overview of the Impact of COVID-19 on this Market:

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.


To get the short-term and long-term impact of COVID-19 on this Market.

Please visit: https://www.fortunebusinessinsights.com/industry-reports/breast-cancer-therapeutics-market-100163


High Intake of Oral Contraceptives Among Women, Boosting Market

Breast cancer can develop due to reasons such as reduced breast feeding, rise in age of childbearing, undergoing estrogen modifying drug treatments and high intake of oral contraceptive pills. The increase in the number of women complaining of such problems and the successive rise in the number of breast cancer cases are factors boosting the global market for breast cancer therapeutics during the forecast period.

Another factor creating lucrative growth opportunities for breast cancer therapies is the increasing number of obese women. With change in lifestyle and unhealthy food habits, the rate of obesity is increasing by the day. Obesity further causes various health problems such as cardiovascular disorders, gall bladder diseases, diabetes, breathing problems, and breast cancer among others.

North America to Remain Dominant on Account of Presence of Skilled Professionals

The breast cancer treatment market in North America is currently leading the global landscape, supported by the presence of a well-established healthcare infrastructure and rising uptake of advanced facilities in the region. In 2018, North America generated a revenue of US$ 8,033.8 Mn, because of the increasing prevalence of breast cancer in the region.

In addition to this, the region boasts presence of several leading market players and skilled professionals. Besides this, governments of developed nations such as Canada and the U.S. are providing health insurance for cancer diagnostics. Spurred by these factors the breast cancer therapeutics market is likely to flourish in North America to emerge dominant.


Quick Buy -  Breast Cancer Therapeutics Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/100163


Looming Patent Expiries Fuels Demand for Generic Drugs

The global breast cancer therapeutics market is likely to witness the prevalence of high competition. According to the report, Genentech, Inc. (F. Hoffmann-La Roche Ltd) held the dominant share in the market in 2018. Growth of the company is backed by its diverse product portfolio in targeted and chemotherapy segment.

With the expiry of most patent drugs in the market, there is an increased demand for their generic counterparts. Such factors are propelling vendors to invest more on research and development and develop generic drugs for breast cancer treatment. The introduction of combination drug therapy is anticipated to create better growth opportunities for the market.


List of the players operating in the global breast cancer therapeutics market:

  • Puma Biotechnology, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • GlaxoSmithKline plc.
  • Eli Lilly and Company
  • Novartis International AG
  • AstraZeneca plc
  • F. Hoffmann-La Roche Ltd.
  • Sanofi S.A.
  • GlaxoSmithKline plc
  • Pfizer, Inc.


Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/breast-cancer-therapeutics-market-100163


Breast Cancer Therapeutics Market Segmentations:

By Therapy           

•              Targeted Therapy

o              Abemaciclib

o              Ado-Trastuzumab Emtansine

o              Everolimus

o              Trastuzumab

o              Ribociclib

o              Palbociclib

o              Pertuzumab

o              Olaparib

o              Others

•              Hormonal Therapy

o              Selective Estrogen Receptor Modulators (SERMs)

o              Aromatase Inhibitors

o              Estrogen Receptor Downregulators (ERDs)

•              Chemotherapy

By Distribution Channel    

•              Hospital Pharmacies

•              Retail Pharmacies

•              Online Pharmacies

•              Others

By Cancer Type   

•              Hormone Receptor

•              HER2+

By Geography      

•              North America (U.S. and Canada)

•              Europe (Germany, U.K., France, Italy, Spain, Scandinavia, and Rest of Europe)

•              Asia Pacific (China, India, Japan, Australia, South East Asia and Rest of Asia Pacific)

•              Latin America (Brazil, Mexico and Rest of Latin America

•              Middle East & Africa (GCC, South Africa and Rest of Middle East & Africa)


Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/breast-cancer-therapeutics-market-100163


Have a Look at Related Reports:

Lung Cancer Therapeutics Market Share and Global Trend By Therapy (Targeted, Therapy, Immunotherapy, Chemotherapy), By Cancer Type (Non-small cell lung cancer (NSCLC), Small cell lung cancer (SCLC)), By Distribution Channel(Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography Forecast till 2026

Cancer Biomarkers Market Share & Industry Analysis, By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, and Others), By Biomarker Type (PSA, HER-2, EGFR, KRAS, and Others), By End User (Pharmaceutical & Biotechnology Companies, Diagnostics & Research Laboratories, Hospitals & Specialty Clinics, and Others), and Regional Forecast, 2019-2026

Blood Screening Market Share & Industry Analysis, By Product Type (Instruments, and Reagents & Kits), By Technology (Molecular Tests, and Serology Tests), By End User (Independent Clinical Laboratories, Hospital-based Laboratories, and Others), and Regional Forecast, 2019-2026

Infusion Pump Market Share & Industry Analysis, By Type (Volumetric Pumps, Syringe Pumps, Enteral Pumps, Insulin Pumps, Elastomeric Pumps, Implantable Pumps, and PCA Pumps), By Application (Diabetes, Oncology, Pain Management, and Others), By End User (Hospitals & Clinics, Ambulatory Care Settings, Home Care Settings, and Others), and Regional Forecast, 2019-2026

Medical Carts Market Share & Industry Analysis, By Type (Anesthesia Carts, Emergency Carts, Procedure Carts, Telemedicine Carts and Others), By Material Type (Metal, Plastic, and Others), By End User (Hospitals, Physician Offices, Others) and Regional Forecast, 2019-2026


About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.


Contact Us:

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs


Press Release: https://www.fortunebusinessinsights.com/press-release/breast-cancer-therapeutics-market-9089

Primary Logo

Powered by EIN News


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release